{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:42:03Z","timestamp":1787244123906,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116208","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:07:14Z","timestamp":1706814434000},"page":"116208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management"],"prefix":"10.1016","volume":"267","author":[{"given":"Zhenrui","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116208_bib1","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/acs.jmedchem.1c00028","article-title":"Novel approaches, drug candidates, and targets in pain drug discovery","volume":"64","author":"Obeng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in achieving opioid analgesia without side effects","volume":"9","author":"Machelska","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116208_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116208_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2024.116208_bib5","first-page":"642","article-title":"Role of non-steroidal anti-inflammatory drugs on upper gastrointestinal bleeding, Polski merkuriusz lekarski","volume":"19","author":"Sulek","year":"2005","journal-title":"organ Polskiego Towarzystwa Lekarskiego"},{"key":"10.1016\/j.ejmech.2024.116208_bib6","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational design of multitarget-directed ligands: strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111953","article-title":"A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents","volume":"188","author":"Tripathi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acs.jmedchem.6b00538","article-title":"Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors","volume":"60","author":"Tuo","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/cn300015x","article-title":"\"Redundancy\" of endocannabinoid inactivation: new challenges and opportunities for pain control","volume":"3","author":"Fabiana","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116208_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-018-3439-0","article-title":"Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model","volume":"453","author":"Naziroglu","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2024.116208_bib11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.pain.2012.06.016","article-title":"Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after all","volume":"153","author":"Di Marzo","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2024.116208_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fphar.2016.00257","article-title":"Dual-acting compounds targeting endocannabinoid and endovanilloid systems-a novel treatment option for chronic pain management","volume":"7","author":"Malek","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116208_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13543776.2021.1854225","article-title":"A patent review of transient receptor potential vanilloid type 1 modulators (2014-present)","volume":"31","author":"Gao","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2024.116208_bib14","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1021\/jm070678q","article-title":"New N-arachidonoylserotonin analogues with potential \"dual\" mechanism of action against pain","volume":"50","author":"Ortar","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/cmdc.201600111","article-title":"TRPV1-FAAH-COX: the couples game in pain treatment","volume":"11","author":"Aiello","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116208_bib16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bmcl.2016.01.071","article-title":"Arylboronic acids as dual-action FAAH and TRPV1 ligands","volume":"26","author":"Morera","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116208_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.phrs.2016.06.012","article-title":"The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain","volume":"111","author":"Malek","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116208_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-8069-7-7","article-title":"The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats","volume":"7","author":"de Novellis","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejmech.2024.116208_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/ijms19020342","article-title":"Molecular understanding of the activation of CB1 and blockade of TRPV1 receptors: implications for novel treatment strategies in osteoarthritis","volume":"19","author":"Mlost","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116208_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bmcl.2012.10.137","article-title":"Tetrahydro-\u03b2-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels","volume":"23","author":"Giorgio","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116208_bib21","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1016\/j.bmcl.2009.09.033","article-title":"Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands","volume":"19","author":"Morera","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116208_bib22","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.bmcl.2015.04.024","article-title":"J. Lee, alpha-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists","volume":"25","author":"Tran","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116208_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/JPR.S228577","article-title":"Role of melatonin in the regulation of pain","volume":"13","author":"Xie","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejmech.2024.116208_bib24","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/acs.jnatprod.5b00599","article-title":"Partial activation and inhibition of TRPV1 channels by evodiamine and rutaecarpine, two major components of the fruits of Evodia rutaecarpa","volume":"79","author":"Wang","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116208_bib25","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1021\/jm300780p","article-title":"2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region","volume":"55","author":"Kim","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114191","article-title":"Discovery of (S)-N-(3-isopropylphenyl)-2-(5-phenylthiazol-2-yl)pyrrolidine-1-carboxamide as potent and brain-penetrant TRPV1 antagonist","volume":"233","author":"Qiao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105229","article-title":"Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists","volume":"115","author":"Hu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116208_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2024.116208_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2024.116208_bib30","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.pain.2013.06.040","article-title":"TRPV1 channels make major contributions to behavioral hypersensitivity and spontaneous activity in nociceptors after spinal cord injury","volume":"154","author":"Wu","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2024.116208_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.phrs.2010.02.001","article-title":"The dual fatty acid amide hydrolase\/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice","volume":"61","author":"Costa","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116208_bib32","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-023-38162-9","article-title":"Human TRPV1 structure and inhibition by the analgesic SB-366791","volume":"14","author":"Neuberger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116208_bib33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/geno.1998.5597","article-title":"Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation","volume":"54","author":"Wan","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.ejmech.2024.116208_bib34","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/ja902694n","article-title":"Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by \u03b1-ketoheterocycle inhibitors revealed from cocrystal structures","volume":"131","author":"Mileni","year":"2009","journal-title":"J. Am. Chem. Soc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T14:18:48Z","timestamp":1735049928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"alternative-id":["S0223523424000886"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116208","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116208"}}